<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Although <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo>-induced <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> is generally accepted as cause of <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> in thalassemic patients, cardiogenic embolism has been recently suggested as another possible <z:hpo ids='HP_0001297'>stroke</z:hpo> etiology </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We present four adult β-<z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">thalassemia major</z:e> patients with manifest cardiac involvement who suffered territorial <z:hpo ids='HP_0001297'>strokes</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: In the presence of siderotoxic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>, we assumed cardiogenic embolism as etiology of <z:hpo ids='HP_0001297'>stroke</z:hpo> and initiated oral anticoagulation as preventive medication </plain></SENT>
<SENT sid="3" pm="."><plain>Two of our patients were the first β-<z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">thalassemia major</z:e> patients who underwent successful thrombolysis with rtPA </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS: Cardioembolism seems to be the cause of <z:hpo ids='HP_0001297'>stroke</z:hpo> in cases of β-<z:e sem="disease" ids="C0002875" disease_type="Disease or Syndrome" abbrv="">thalassemia major</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Thrombolysis can be applied in the setting of <z:hpo ids='HP_0011009'>acute</z:hpo> brain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> in such high risk patients </plain></SENT>
</text></document>